Literature DB >> 14314772

POSSIBLE ANTIGENIC RELATIONSHIP BETWEEN VARICELLA ZOSTER VIRUS AND HERPES SIMPLEX VIRUS.

J G KAPSENBERG.   

Abstract

Entities:  

Keywords:  COMPLEMENT FIXATION TESTS; HERPESVIRUS INFECTIONS; VARICELLA-ZOSTER VIRUS

Mesh:

Year:  1964        PMID: 14314772     DOI: 10.1007/bf01241422

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  9 in total

1.  GROWTH OF VARICELLA-ZOSTER VIRUS IN HUMAN THYROID TISSUE CULTURES.

Authors:  A E CAUNT
Journal:  Lancet       Date:  1963-11-09       Impact factor: 79.321

2.  Morphology of varicella (chicken pox) virus.

Authors:  J D ALMEIDA; A F HOWATSON; M G WILLIAMS
Journal:  Virology       Date:  1962-03       Impact factor: 3.616

3.  Chickenpox and herpes zoster. 1. Complement fixation studies.

Authors:  D TAYLOR-ROBINSON; A W DOWNIE
Journal:  Br J Exp Pathol       Date:  1959-08

4.  Chickenpox and herpes zoster. III. Tissue culture studies.

Authors:  D TAYLOR-ROBINSON
Journal:  Br J Exp Pathol       Date:  1959-12

5.  Chickenpox and herpes zoster. II. Ouchterlony precipitation studies.

Authors:  D TAYLOR-ROBINSON; C J RONDLE
Journal:  Br J Exp Pathol       Date:  1959-12

6.  The soluble antigens of varicella-zoster virus produced in tissue culture.

Authors:  A E CAUNT; C J RONDLE; A W DOWNIE
Journal:  J Hyg (Lond)       Date:  1961-06

7.  Isolation and antigen production of herpes simplex virus in the chorioallantoic membrane of duck embryos.

Authors:  R GISPEN; B SAATHOF
Journal:  Antonie Van Leeuwenhoek       Date:  1960       Impact factor: 2.271

8.  Evaluation of a trivalent adenovirus vaccine for prevention of acute respiratory disease in naval recruits.

Authors:  B F GUNDELFINGER; M J HANTOVER; J A BELL; C G LOOSLI; W P ROWE
Journal:  Am J Hyg       Date:  1958-09

9.  The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.

Authors:  T H WELLER; H M WITTON
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

  9 in total
  22 in total

1.  Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors:  B Forghani; N J Schmidt; J Dennis
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

2.  Varicella-zoster plaque assay and plaque reduction neutralization test by the immunoperoxidase technique.

Authors:  G Gerna; R W Chambers
Journal:  J Clin Microbiol       Date:  1976-11       Impact factor: 5.948

3.  Quantitation of antibodies to varicella-zoster virus by immune adherence hemagglutination.

Authors:  C L Wong; S Castriciano; M A Chernesky; W E Rawls
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

4.  Sensitive solid-phase radioimmunoassay for detection of human immunoglobulin G antibodies to varicella-zoster virus.

Authors:  M G Friedman; S Leventon-Kriss; I Sarov
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

5.  Antigenic relationship between human cytomegalovirus, herpes simplex, and varicella-zoster virus studied by complement-fixation.

Authors:  U Krech; M Jung
Journal:  Arch Gesamte Virusforsch       Date:  1971

6.  Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.

Authors:  G J Schaap; J Huisman
Journal:  Arch Gesamte Virusforsch       Date:  1968

7.  The incidence of Herpesvirus hominis antibody in the population.

Authors:  I W Smith; J F Peutherer; F O MacCallum
Journal:  J Hyg (Lond)       Date:  1967-09

8.  Varicella virus in HeLa cells.

Authors:  A Svedmyr
Journal:  Arch Gesamte Virusforsch       Date:  1965

9.  Neutralization tests with varicella-zoster virus.

Authors:  A E Caunt; D G Shaw
Journal:  J Hyg (Lond)       Date:  1969-06

10.  Complement-fixing reactivity of Varicella-Zoster virus subunit antigens with sera from homotypic infections and heterotypic Herpes simplex virus infections.

Authors:  N J Schmidt; J Dennis; E H Lennette
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.